Unknown

Dataset Information

Mutation analysis of 419 family and prenatal diagnosis of 339 cases of spinal muscular atrophy in China.


ABSTRACT:

Background

Spinal muscular atrophy (SMA) is a common and lethal autosomal recessive neurodegenerative disease caused by mutations in the survival motor neuron 1 (SMN1) gene. At present, gene therapy medicine for SMA, i.e., Spinraza (Nusinersen), has been approved by the FDA, bringing hope to SMA patients and families. Accurate diagnosis is essential for treatment. Our goal was to detect genetic mutations in SMA patients in China and to show the results of the prenatal diagnosis of SMA.

Methods

In this study, we examined 419 patients in our hospital from January 2010 to September 2019. Multiplex ligation-dependent probe amplification analysis was used to determine the copy numbers of SMN1 and SMN2. Long-range PCR combined with nested PCR was used to detect point mutations in

SUBMITTER: Sun Y 

PROVIDER: S-EPMC7302341 | biostudies-literature | 2020 Jun

REPOSITORIES: biostudies-literature